Figure 3 identifies the nine core targets of CDCA in the treatment of ALI as HSP90AA1, STAT3, HSP90AB1, EP300, NFKB1, CD4, NR1H4, MTOR, and TLR4. Here, CD4 is linked to acute respiratory distress syndrome.